Drug Type Synthetic peptide |
Synonyms Ciclosporin G, Cyclosporin G, Nva2 cyclosporine + [5] |
Target |
Mechanism CaN inhibitors(Calcineurin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC63H113N11O12 |
InChIKeyZMKGDQSIRSGUDJ-VSROPUKISA-N |
CAS Registry74436-00-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Phase 3 | - | - | |
Rheumatoid Arthritis | Phase 3 | - | - | |
Systemic Lupus Erythematosus | Phase 3 | - | - |
Not Applicable | - | 29 | Topical ciclosporin 0.05% ophthalmic emulsion | wyxpklbluk(jximyzpghv) = rekzhxcqcp rjqasocxqc (yxgisdhear ) View more | - | 01 May 2006 |